Celldex Therapeutics Cash Flow Statement (2010-2025) | CLDX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-16.54M	-13.37M	-20.45M	-20.18M	-23.05M	-36.00M	-26.78M	-26.49M	-29.36M	-30.50M	-38.26M	-43.31M	-32.81M	-35.84M	-42.12M	-47.09M	-53.80M	-56.60M	-67.04M	-81.32M
Share-based Compensation (Quarter)	1.27M	1.51M	3.03M	3.14M	3.15M	3.45M	4.50M	4.51M	4.34M	5.22M	7.12M	7.21M	7.20M	7.64M	9.62M	9.78M	9.32M	9.19M	8.80M	8.91M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	0.02M	1.34M	3.32M	-0.96M	0.02M	1.76M	0.12M	-0.00M	4.97M	1.03M	1.07M	6.38M	1.01M	2.47M	2.42M	-0.00M	-0.00M	1.96M	0.29M
Asset Writedowns and Impairment (Quarter)			3.50M
Non-cash Items (Quarter)	0.98M	36.00M	33.70M	84.70M	29.50M	2.14M	46.70M	42.90M	38.30M	2.90M	3.09M	3.26M	3.28M	93.10M	3.75M	3.98M	4.23M	4.93M	5.13M	5.28M
Cash from Operations (Quarter)	-18.08M	-11.93M	-16.37M	-14.52M	-24.53M	-22.24M	-35.19M	-21.76M	-28.57M	-27.20M	-18.99M	-32.53M	-40.64M	-29.33M	-55.34M	-32.48M	-54.37M	-44.01M	-48.63M	-63.94M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)	0.05M	0.12M	3.23M	-0.20M	-0.77M	-0.54M	-0.06M	0.52M	1.26M	1.16M	1.63M	2.18M	3.31M	4.74M	4.33M	3.36M	2.27M	1.69M	1.02M	0.88M
Depreciation & Amortization (CF) (Quarter)	0.78M	0.76M	0.75M	0.78M	0.81M	0.74M	0.67M	0.67M	0.73M	0.76M	0.77M	0.76M	0.78M	0.80M	0.79M	0.82M	0.87M	0.87M	0.82M	0.82M
Change in Working Capital
Change in Receivables (Quarter)	0.03M	-1.33M	-0.24M	-0.03M	0.07M	-0.15M	0.09M	0.16M	0.97M	-1.20M	0.13M	2.38M	0.04M	-1.14M	-0.68M	-0.15M	0.36M	-0.97M		1.93M
Change in Accured Expenses (Quarter)	-0.58M	-3.40M	0.13M	-0.55M	-2.74M	1.88M	4.12M	-0.54M	-3.45M	1.73M	7.23M	3.88M	-1.47M	-0.63M	-2.69M	16.43M	-8.72M	2.09M	13.06M	4.60M
Investing Activities
Capital Expenditures (Quarter)	0.57M	0.14M	0.18M	0.35M	0.57M	0.67M	0.34M	0.23M	0.58M	0.41M	0.16M	0.67M	0.34M	0.27M	0.55M	0.76M	0.27M	0.73M	0.44M	1.28M
Sales of Property, Plant and Equipment (Quarter)	0.02M		0.00M	0.00M			0.07M
Change in Acquisitions & Divestments (Quarter)	78.00M	38.00M	13.00M	45.95M	27.84M	78.91M	86.11M	87.80M	127.00M	83.15M	39.55M	70.89M	77.31M	122.06M	148.36M	153.98M	195.04M	172.84M	116.92M	111.50M
Cash from Investing Activities (Quarter)	43.49M	-13.91M	-226.79M	-18.94M	10.38M	25.28M	23.07M	31.21M	52.57M	1.16M	11.65M	-171.16M	-315.21M	-46.72M	47.76M	24.05M	42.95M	49.85M	60.85M	55.42M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	0.07M	-0.03M	2.00M	0.43M	0.30M	0.07M	2.31M	1.40M	0.69M	0.13M	0.26M	215.14M	432.30M	-424.77M	424.77M	-423.15M	0.20M	0.06M	0.77M	1.35M
Misc.
Cash from Financing Activities (Quarter)	0.07M	-0.03M	271.90M	0.43M	0.30M	0.07M	2.31M	1.40M	0.69M	0.13M	0.26M	217.37M	436.11M	3.71M	1.24M	0.39M	0.20M	0.06M	0.77M	1.35M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	25.48M	-25.87M	28.74M	-33.04M	-13.85M	3.11M	-9.82M	10.85M	24.69M	-25.90M	-7.09M	13.68M	80.26M	-72.34M	-6.34M	-8.04M	-11.22M	5.91M	12.99M	-7.17M
Free Cash Flow (Quarter)	-18.65M	-12.07M	-16.56M	-14.88M	-25.11M	-22.92M	-35.54M	-22.00M	-29.15M	-27.61M	-19.15M	-33.20M	-40.98M	-29.60M	-55.88M	-33.23M	-54.64M	-44.73M	-49.07M	-65.22M
Net Cash Flow (Quarter)	25.48M	-25.87M	28.74M	-33.04M	-13.85M	3.11M	-9.82M	10.85M	24.69M	-25.90M	-7.09M	13.68M	80.26M	-72.34M	-6.34M	-8.04M	-11.22M	5.91M	12.99M	-7.17M

Research Tools

Celldex Therapeutics Cash Flow Statement (2010-2025) | CLDX

Create an account

Sign In

Reset Password